GOLDMAN SACHS GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (FDMT)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol: FDMT
Shares outstanding: 57,147,700 shares
Disclosed Ownership: 4,286,077 shares
Ownership: 7.5%
Form type: SCHEDULE 13G/A
Filing time: 09 Feb 2026, 16:05:49 UTC
Date of event: 31 Dec 2025
Previous filing: 10 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	7.5%	4,286,077	0	4,286,060	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	7.5%	4,286,077	0	4,286,060	Name: Sam Prashanth	Attorney-in-fact